CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Triochem Products Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Triochem Products Ltd
4th Floor
Sanbava Chambers, Sir. P. M. Road, Fort
Phone: +91 2222663150p:+91 2222663150 MUMBAI, 400001  India Ticker: 512101512101
Business Summary
Triochem Products Limited is an India-based company that is engaged primarily in the business of manufacturing and export of pharmaceuticals products, active pharmaceutical ingredients (APIs) and chemicals. The Company operates in the chemical and pharmaceuticals segment. The Company’s product range includes iodine compounds, citrates and piperazine salts. The Company operates in two geographic segments: Within India, which includes sales to customers located within India, and Outside India, which includes sales to customers located outside India. The Company's markets include Europe (Germany, France, the Netherlands, and the United Kingdom), America (the United States, Brazil, Mexico, and Guatemala) and Southeast Asia (Korea, Indonesia, Taiwan, and Australia).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Ramu S.Deora 3/30/2015
Chief Financial Officer PuranParmar 3/30/2015 3/30/2015
Compliance Officer, Company Secretary Ureca S.Shirole 11/14/2019 11/14/2019
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 245,000 (As of 9/30/2023)
Shareholders: 82
Stock Exchange: BOM
Fax Number: +91 2222024657


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024